Description:

Study ID: 101468/218 Clinical Study ID: SKF-101468/218 Study Title:A Single-Blind, Randomised, Placebo-Controlled, Parallel-Group, Multicentre, Phase IIa Study to Determine the Pharmacokinetics and Tolerability of Ropinirole in Patients Suffering from Restless Legs Syndrome (RLS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: phase 2 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: requip Study Indication: Restless Legs Syndrome

Keywords:
Versions (2) ▾
  1. 4/27/20
  2. 9/20/21
Copyright Holder:
GlaxoSmithKline
Uploaded on:

September 20, 2021

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 4.0
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Pharmacokinetics and Tolerability of Ropinirole in Patients Suffering from Restless Legs Syndrome 101468/218

Dose Level 1, Day1, Pre-dose - Prior Medication; Pregnancy Test; Alcohol Breath Test; Drug Screening (Urine); Vital Signs

Administrative
Prior Medication
Has the subject taken any medication within 1 week PRIOR to the first dose of study medication?
Prior Medication
Prior Medication - Route
Prior Medication - Continuing at end of study?
Pregnancy Test
Was a pregnancy test carried out?
Pregnancy test result
Alcohol Breath Test
Was an alcohol breath test carried out?
Alcohol breath test result
Drug Screening (Urine)
Were there any contra-indicated drugs detected?
Vital Signs
mm[Hg]
mm[Hg]
beats/min
mm[Hg]
mm[Hg]
beats/min

Similar models